Sebana Medical

Sebana Medical is a fully integrated, fast-growing biotech company founded in Nazareth, Israel, that aims to address unmet needs in the field of soft tissue augmentation. Using its patented technological platform, Sebana develops and plans to manufacture and commercialize novel therapeutics, including its lead candidate, SEBA™, which has the potential to prevent the resorption of autologous fat grafts. The company's professional team of experts in aesthetic care, dermal filling, biopharmaceutical development, and business development, supported by an advisory board of leading clinicians and researchers, is committed to bringing SEBA™ to market for wrinkle removal and breast augmentation. With no treatments currently available for preventing fat grafts from being resorbed in clinics, Sebana's SEBA™ has the potential to become a game-changer for dermal filling and address the significant challenges associated with traditional fat grafting techniques.